Dr. Marketa Marvanova Named Dean of School of Pharmacy
Dr. Marketa Marvanova will join Pacific University's College of Health Professions as dean of the School of Pharmacy, effective July 28.
Dr. Marvanova previously served as dean and professor of the Skaggs School of Pharmacy at the University of Montana. Between July 2020 and September 2021, she also served as acting dean of the College of Health, overseeing five other accredited health profession schools.
She holds a master of science in pharmacy, a doctor of pharmacy and a PhD in pathological neurobiochemistry from the Charles University (Czech Republic), as well as a PhD in neuropharmacology from the University of Eastern Finland. She completed a medical research fellowship in neuropharmacology at Vanderbilt University School of Medicine and a Parkinson’s disease traineeship at Northwestern University. She is a Board-Certified Psychiatric Pharmacist and Geriatric Pharmacist and Fellow of the American Society of Consultant Pharmacists. Her clinical expertise is neuropsychiatry and geriatrics, and she has practiced in a variety of inpatient and outpatient settings such as Vanderbilt University Medical Center in Nashville, Tenn., Rush University Medical Center and Northwestern University in Chicago.
She is member of the editorial board for Continuum: Life-long Learning in Neurology (American Academy of Neurology) and also serves as a clinical pharmacy specialist consultant in neurology and psychiatry for Lexicomp, Wolters Kluwer. She dedicates professional service to pharmacy education and pharmacy profession and is currently a member of Board of Pharmacy Specialty Council in Psychiatric Pharmacy and previously the Board for Geriatric Pharmacy.
Dr. Marvanova is also dedicated to service to community and patient support groups for epilepsy, Parkinson’s disease, depression and bipolar disorders. Her early research was oriented toward basic bench-lab research in neuropharmacology, neurophysiology, and drug discovery for management of neurodegenerative disorders, primarily Parkinson’s disease. She later transitioned to clinical and multi-state outcome-based research in healthcare disparities among older adults and scholarship of teaching and learning.